[25] The mixed observational results in the literature might be explained by differences in effect on CRC risk of the specific variants included, perhaps suggesting the importance of capturing a sufficient and representative amount of genetic variation present in the mTOR-PI3k-Akt pathway in the population. This evidence concerns the gene AKT1 and colorectal carcinoma.